Delivery Order SPE2DB24D1034-SPE2DB25FWEA8
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication, with a ceiling value of $3,374.40 and a performance period through May 7, 2025. The contract is not set aside and was awarded as a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a large Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication. The contract has a ceiling value of $1,054.35 and a period of performance through May 8, 2025. It is a firm-fixed-price contract, which indicates the price will not change regardless of the contractor's costs. The contract is not...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication, with a ceiling value of $1,397.18. The contract is a firm fixed price, non-set-aside award with a period of performance through May 13, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $3,757.80 and is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication. The contract has a performance period through May 5, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication, with a ceiling value of $1,119.03 and a period of performance through June 30, 2025. The contract is a firm fixed-price delivery order and is not set aside for any special designation. Amerisourcebergen Drug Corp holds...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication, with a ceiling value of $1,054.35 and a period of performance through June 12, 2025. The contract is designated as a firm fixed-price delivery order and is not set aside for any specific business type....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication, with a ceiling value of $5,103.49 and a period of performance through May 30, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication, and has a ceiling value of $39,378.06. The contract is a firm fixed-price delivery order with a performance period extending through June 30, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication, with a ceiling value of $1,782.76 and a period of performance through June 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication, with a ceiling value of $1,758.48 and a period of performance through May 14, 2025. The contract is a firm fixed-price, non-set-aside delivery order, indicating open competition. AmerisourceBergen Drug Corp is the prime...
- SPE2DB24D1034Indefinite Delivery Contract
- SPE2DB24D1034-SPE2DB25FWEA8Delivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication, with a ceiling value of $3,640.20 and a period of performance through July 3, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to supply a wide range of pharmaceutical products and medical supplies to various government agencies, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 7/2/25 |